CSPC Pharmaceutical Group (01093): Phase I clinical trial of SYH2083 eye drops for dry eye disease officially launched in China

Zhitong Finance APP news, CSPC Pharmaceutical Group (01093) issued an announcement that the Phase I clinical trial (SYH2083-001) of SYH2083 eye drops (the product) developed by the Group for the treatment of dry eye disease has officially been initiated in China.